Skip to main content
ENTA logo

ENTA · Enanta Pharmaceuticals Inc · Proposed Sales

Track ENTA — free
$12.96 +0.26 (+2.05%) At close · Sep 11
Market Cap
$377.47M
Shares
29.13M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-12-05 Luly Jay R. 4,743
2024-07-11 Scott T. Rottinghaus 11,945
2024-06-17 Tara Lynn Kieffer 7,266
2023-12-12 Vance Terry 15,295
Showing 1–4 of 4 filings
Key facts CIK 1177648 CUSIP 29251M106 13F (30d) 40 filings 40 filers Visit website Investor relations